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This study identifies the adverse events related to the use of central venous catheters 
(CVC) in newborns admitted to a neonatal care unit. This is a quantitative, descriptive and  
retrospective study. The population consisted of 167 newborns admitted in the neonatal 
unit of the Hospital de Clínicas at Porto Alegre, RS, Brazil which used CVCs inserted 
through percutaneous puncture (PICC) and surgical insertion, totaling 241 catheters. There 
was a higher prevalence of mechanical adverse events in the PICC line insertions, with 
a preponderance of catheter occlusions (19.44%) and ruptures (8.8%). The surgically 
inserted CVCs had a higher prevalence of catheter-related infectious adverse events with 
the most common being clinical sepsis (16%). This study suggests that the correct insertion 
technique should be used and a specialized team should monitor the CVCs to ensure safety 
and prevent adverse events.
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Eventos adversos relacionados ao uso de cateteres venosos centrais 
em recém-nascidos hospitalizados
O objetivo deste estudo foi identificar os eventos adversos relacionados ao uso de 
cateteres venosos centrais (CVC), em recém-nascidos internados em unidade neonatal. 
Trata-se de pesquisa quantitativa, descritiva, retrospectiva. A população foi constituída 
por 167 neonatos internados na unidade neonatal do Hospital de Clínicas de Porto Alegre 
que utilizaram CVCs, inseridos por punção percutânea (PICC) e inserção cirúrgica, 
totalizando 241 cateteres. Nos PICCs houve maior prevalência de eventos adversos 
mecânicos, predominando a oclusão (19,44%) e a ruptura do cateter (8,8%). Os CVCs 
por inserção cirúrgica apresentaram maior prevalência dos eventos adversos infecciosos 
relacionados ao cateter, sendo o mais frequente a sepse clínica (16%). O estudo sugere 
que, para maior segurança do uso de CVCs, é importante que seja utilizada a técnica 
correta de inserção do cateter e realizado o acompanhamento dos CVCs por equipe 
especializada e atenta para a prevenção de eventos adversos.
Descritores: Recém-Nascido; Cateterismo Venoso Central / Efeitos Adversos.
Eventos adversos relacionados con el uso de catéteres venosos 
centrales en recién nacidos hospitalizados
El objetivo de este estudio fue identificar los eventos adversos relacionados con el uso 
de catéteres venosos centrales (CVC), en recién nacidos internados en una unidad 
neonatal. Se trata de investigación cuantitativa, descriptiva, retrospectiva. La población 
fue constituida por 167 neonatos internados en la unidad neonatal del Hospital de 
Clínicas de Porto Alegre que utilizaron CVCs, inseridos por punción percutánea (PICC) 
e inserción quirúrgica, totalizando 241 catéteres. En los PICCs hubo mayor incidencia 
de eventos adversos mecánicos, predominando la oclusión (19,44%) y la ruptura del 
catéter (8,8%). Los CVCs por inserción quirúrgica presentaron la mayor incidencia de 
los eventos adversos infecciosos relacionados al catéter, siendo el más frecuente la 
sepsis clínica (16%). El estudio sugiere que, para mayor seguridad del uso de CVCs, es 
importante que sea utilizada la técnica correcta de inserción del catéter y realizado el 
acompañamiento de los CVCs por un equipo especializado y atento a la prevención de 
eventos adversos.
Descriptores: Recién Nacido; Cateterismo Venoso Central / Efectos Adversos.
Introduction
CVC is a common practice in Neonatal Intensive 
Care Units (NICU) and provides safe vascular access to 
newborns, though it is not an innocuous procedure and 
oftentimes is associated with adverse events(1). 
CVCs might be tunneled, non-tunneled, 
Peripherally Inserted Central Catheters (PICC) or totally 
implantable(2). The catheters most used in neonatology 
are non-tunneled and PICCs. Specialized nurses can 
practice PICC line insertion at bedside through the 
percutaneous puncture of peripheral veins. The insertion 
of catheters through the percutaneous puncture of the 
large veins of the neck and thorax and the insertion of 
catheters through phlebotomy can only be performed 
by surgeons.  
An adverse event is currently defined as a non-
intentional lesion that results in temporary or permanent 
incapacity and/or extended time of hospitalization or 
death as a consequence of delivered care(3).
Adverse events related to the use of CVC are split 
into infectious adverse events, mechanical adverse 
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events and thrombosis. According to the literature, 
mechanical adverse events occur in 5 to 19% of patients 
with a CVC, infectious adverse events in 5 to 26% and 
thrombosis in 2 to 26%(4). 
Even with the possibility of the occurrence of 
adverse events, the use of CVCs should not be discarded 
because the survival of many newborns depends on 
their use. The decision to insert a CVC includes the 
consideration of risks and benefits. 
Procedures to identify adverse events by the 
healthcare facility are the first step in constructing a 
care system designed to prevent errors. The American 
Academy of Pediatrics recommends identifying errors 
and studying their patterns of occurrence so as to 
diminish the chances of adverse events occurring(5).
One study suggests that indicators of results 
such as adverse events are essential tools to measure 
quality because they indicate aspects of care that can be 
improved and make care delivery safer for patients(6). 
Realizing that the use of CVCs is essential for 
the survival of most of the newborns hospitalized in 
NICUs and that the occurrence of adverse events in 
this population can lead to major and irreversible 
consequences due to the newborns’ fragility, this study 
identified the adverse events related to the use of CVCs 
in newborns hospitalized in NICUs.
Methods
This quantitative, descriptive and retrospective 
study was carried out through the search of the medical 
records of patients hospitalized in the NICU of the 
Hospital das Clinicas at Porto Alegre, RS, Brazil between 
January and December 2007. The population was 
composed of newborns admitted into the NICU of the 
Hospital das Clinicas at Porto Alegre between January 
1st and December 31st 2007, who received a CVC. The 
participants were selected as an intentional convenience 
sample(7). All newborns who received a CVC through 
percutaneous puncture or surgical insertion in 2007 were 
included in the study. The exclusion criteria were: venous 
catheters inserted by incision in the navel vein, CVCs 
inserted in hospitalization units other than the neonatal 
unit and/or other hospital facility, and central venous 
catheters not removed by the team from the neonatal 
unit. This situation occurs when a newborn is transferred 
with the catheter from the neonatal unit/Hospital das 
Clinicas of Porto Alegre to another hospitalization unit 
or facility. 
Participants were searched out through the numbers 
of medical records found in the forms of patients 
receiving CVCs. These forms are filled out by nurses. 
A sample of 167 newborns, totaling 241 catheters, 
was used. Data were collected from patients’ medical 
records. The researcher herself collected information 
using an instrument. This study was supported by the 
Research Incentive Fund of the Hospital de Clínicas de 
Porto Alegre (FIPE/HCPA).
The following definitions were adopted regarding 
the type of CVC used:
- Peripherally Inserted Central Catheter (PICC), catheter 
inserted through the percutaneous puncture of a 
peripheral vessel.
- Central Venous Catheter through surgical insertion 
(CVCSI), catheter inserted through surgical incision or 
the puncture of a central vein (subclavian, jugular or 
femoral) by a surgeon.
Statistical Analysis
Data were analyzed through descriptive statistics. 
The categorical variables were described by absolute 
frequency and relative percentage; the symmetrical 
quantitative variables were described by the median 
and standard error and the asymmetric variables by the 
median and inter-quantile range. 
Ethical aspects
Ethical standards were complied with through the 
use of consent forms authorizing the use of data. The 
consent form establishes that the project’s researchers are 
required to maintain the privacy of patients whose data 
were collected from medical records and databases of the 
HCPA. It also states that data are solely and exclusively 
used for the development of this research project. 
The Project was approved by the Ethics Research 
Committee at the Federal University of Rio Grande do 
Sul (COMPESQ/EEUFRGS) and at the Hospital de Clínicas 
de Porto Alegre (GPPG/HCPA).
Results
Data from all newborns admitted into the NICU at 
HCPA in 2007 and who received central venous catheters 
surgically inserted or by percutaneous puncture were 
used. 
The sample was composed of 167 newborns: 35 
newborns received two catheters, five received three 
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catheters, seven received four catheters and two 
newborns received five catheters, totaling 241 inserted 
catheters. Regarding the characteristics of the newborns, 
the average gestational age was 33.6 (±4,6) weeks and 
most of the infants were male (53.9%) (Table 1).
Table 1 – Characteristics of the studied newborns, Porto 
Alegre, RS, Brazil, 2007
Characteristics n= 167
Gestational age (weeks)** 33.6±4.6
Weight (grams)** 1,993.4±943.6
Gender (male)* 90 (53.9%)
Deaths* 44 (26.3%)
Days of hospitalization up to the catheter insertion*** 1 (0 – 2)
*Values presented in the form of n(%);**average±standard error and 
***median and inter-quartile interval (P25 - P75)
The CVCs were analyzed according to the type of 
insertion, PICC or CVCSI: 216 PICCs and 25 CVCSIs 
were inserted. In relation to the CVCSI used: 21 double 
lumen catheters were inserted by phlebotomy, three 
double lumen catheters were inserted by percutaneous 
puncture and one monolumen catheter was inserted by 
percutaneous puncture. Of the 241 inserted catheters 
(PICC and CVCSI), 118 presented adverse events: 103 
PICCs and 15 CVCSI.
Infectious adverse events are presented in this 
study in three categories: sepsis with positive blood 
culture, clinical sepsis and suspected infection. We 
considered sepsis with positive blood cultures those 
with laboratory confirmation and those patients who 
were treated with antibiotics. Clinical sepsis were 
those that presented clinical signs of sepsis but had no 
laboratory confirmation and newborns were treated with 
antibiotics. Suspected infection was considered in cases 
with no laboratory confirmation in which patients were 
not treated with antibiotics. 
The most prevalent adverse event in newborns 
who received PICC was catheter occlusion, present in 
19.44% (n=42) of the PICCs. Newborns who received 
CVCSI did not present any cases of catheter occlusion. 
The most prevalent adverse event in these patients was 
clinical sepsis, present in 16% (n=4) of the catheters 
(Table 2). 
Study data
PICC 
(n=216)
CVCSI 
(n=25)
Catheter’s occlusion* 42 (19.44%) 0 (0%)
Catheter’s rupture* 19 (8.8%) 0 (0%)
Infiltration* 11 (5.09%) 3 (12%)
Clinical sepsis* 9 (4.16%) 4 (16%)
Positive culture from the 
catheter’s tip*
2 (0.93%) 3 (12%)
Suspected infection* 6 (2.78%) 1 (4%)
Positive culture from the 
catheter’s tip *
2 (0.93%) 1 (4%)
Inappropriate location of the 
catheter tip*
6 (2.78%) 1 (4%)
Sepsis with positive blood culture* 5 (2.31%) 3 (12%)
Positive culture from the 
catheter’s tip*
0 (0%) 3 (12%)
Accidental withdrawal* 5 (2.31%) 0 (0%)
Venous thrombosis* 0 (0%) 3 (12%)
Total* 103 (47.67%) 15 (60%)
Table 2 - PICCs and CVCSIs that presented adverse 
events
*Values are presented in the form of n (%)
Of the 44 studied newborns who died, 19 had a 
PICC and none of them had CVCSI. The deaths of these 
newborns were investigated and none were associated 
with the presence of a catheter. 
Discussion
The catheter’s intraluminal occlusion may occur due 
to blood clot or by the formation of fibrin that results from 
the presence of blood in the catheter after inappropriate 
washing of the catheter or retrograde flow; occlusion 
might have other origins not related to thrombosis, 
such as precipitate minerals from infused solutions or 
incompatible drugs(2). Among the studied catheters, the 
rate of occlusion of PICCs was 19.44% (n=42), a rate 
similar to that found in the literature. One study carried 
out with 135 catheters, in patients in a neonatology unit, 
reveals a total of 22.9% (n=31) of catheters developed 
occlusions, similar to these findings(8).
In order to prevent intraluminal occlusion, the use of 
phenytoin and diazepam in a PICC is not recommended 
because crystals form inside the catheter during their 
infusion(2). Other non-recommended actions are: the 
infusion of blood products, due to the risk of hemolysis 
and obstruction(9); collecting blood through the catheter 
because there is a risk of  the catheter’s walls collapsing 
during reflux due to its small caliber. (An exception is 
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PICCs with a Groshong valve.) Some authors report 
the use of urokinase 5000iu/ml or tissue plasminogen 
activator to unblock catheters occluded by blood clots(10-
11). However, the use of these solutions in neonatology 
has to be evaluated because none of these studies was 
carried out with this newborns. 
Unlike the PICCs, CVCSIs did not present any 
cases of occlusion. This might be related to the larger 
caliber of the CVCSI (Fr 4) in relation to the PICCs (Fr 
1.2 or 1.19). In addition to the small caliber used in 
neonatology, the PICC also travels a greater distance 
into the venous network, which can leave the patient 
susceptible to mechanical obstruction due to folds in the 
catheter.
Data in the literature reports a 4 to 5% frequency 
of rupture, which occurred in 19 (8.8%) of the studied 
newborns receiving PICCs. No rupture was reported 
in CVCSIs(8,12). Ruptures in PICCs are associated with 
poorly handling the catheter and infusing with too 
much intraluminal pressure(2). In this study, all ruptures 
occurred at the catheter’s point of insertion; catheter 
rupture may become an adverse event if it occurs 
in the bloodstream. To avoid catheter rupture, it is 
recommended not to use force to infuse any solution 
or to use syringes smaller than 10ml to infuse fluids; 
syringes smaller than this caliber have an infusion 
pressure higher than that supported by PICCs(9,12).
Contamination of central venous catheters may 
occur through direct invasion of microorganisms extant 
on the skin or at the catheter’s point of insertion due to 
inappropriate handling of parenteral solutions and the 
catheter’s connections or endogenous contamination(13). 
The cases of catheter-related sepsis fall in the incidence 
of late onset sepsis. Late onset sepsis has a nosocomial 
origin and occurs within 48 hours of the newborn’s life(14). 
The criteria used in this study to determine catheter-
related infection is similar to another study found in the 
literature(15). The infectious events were split into three 
categories: sepsis with positive blood cultures, clinical 
sepsis and suspected infection. 
Twenty PICCs were removed due to infectious 
causes: five with positive blood cultures, nine due to 
clinical sepsis and six due to suspected infection. Of these 
20 catheters, four (1.9%) presented a positive culture 
of the catheter’s tip. In relation to CVCSI, eight were 
removed due to infectious causes (three with a positive 
blood culture, four due to clinical sepsis and one due 
to suspected infection). Of these eight catheters, seven 
(28%) presented a positive culture of the catheter’s tip. 
One study comparing the use of CVCSI and PICC 
in adults obtained findings similar to those found in 
this study. The study found a total of six (21%) PICCs 
removed due to infection, of which only half were 
confirmed to be catheter-related infections. In the 
cases of CVCSIs, on the other hand, all the 21 catheters 
removed due to catheter-related suspected infection 
were later confirmed cases of infection(10). 
Another study presents the experience of a 
healthcare facility that inserted 135 PICCs into newborns 
over a given period. Only three (2.2%) catheters out of 
135 PICCs were presented as sources of infection(8).
One study reports that the incident rate of PICC-
related sepsis is between 2 and 21%. This study 
suggests that the lower incidence of infection in PICCs, 
when compared to other CVCs, might be related to the 
low concentration of bacteria in peripheral areas (50 to 
100 colonies of bacteria per cm2 of skin) when compared 
to the thorax (1,000 to 10,000 colonies of bacteria per 
cm2 of skin)(12). PICCs are rarely inserted in the thoracic 
region. Sometimes the axillary vein is used to insert 
catheters, though this is the last choice for the insertion 
of PICCs. In this study, only 11 PICCs (5%) were inserted 
in this vein and only one was removed due to sepsis. 
The literature shows that there are microorganisms 
more prevalent in catheter-related primary sepsis. The 
gram-positive cocci are responsible for 65% of infections, 
while the most prevalent are the Staphylococcus 
epidermidis (31%) and the Staphylococcus aureus (14%). 
The gram-negative bacilli account for 30% of infections 
and the most prevalent are the Pseudomonas sp (7%) 
and the Escherichia coli (6%). Infection by Candida SP 
is responsible for the remaining 5% of catheter-related 
infections. However, the most frequent microorganism 
isolated in cultures in this study was the Staphylococcus 
sp coagulase negative(13). Here, four positive cultures 
of catheter tips in PICCs presented colonization by the 
Staphylococcus sp coagulase negative. In the CVCSI, 
of the seven positive cultures of catheter tips, six were 
colonized by Staphylococcus sp coagulase negative and 
one by multiple microbiota. 
To avoid contaminating central venous catheters, 
several measures should be implemented in their 
insertion and maintenance. Central catheter insertion, 
whether it is a PICC or a CVCSI, should be aseptic and 
include measures of barrier precaution such as wearing 
a cap, mask, sterile gown, sterile gloves and drapes. 
It is recommended to wash hands with chlorhexidine 
detergent or alcohol gel before and after contact with 
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the catheter during CVC maintenance. The dressing has 
to be changed every seven days or when it is wet or 
for other reasons taken off, change taps, equipment 
and extensions every 72 hours and the equipment 
for parenteral nutrition should be changed every 24 
hours, always swabbing the connections and taps of 
the catheter with 10% concentration of alcohol  before 
handling them(9). 
The literature describes the experience of a 
hospital where the rates of PICC-related infection 
significantly decreased after the implementation of 
a “PICC maintenance team”. This team, composed 
of a neonatologist (fellow), who follows-up preterm 
newborns, and two nurses, is responsible for proactive 
care through the daily inspection of catheters and has 
the autonomous authority to remove or retract it. This 
protocol diminished the rates of PICC-related infections 
from 25 to 7.1% in preterm newborns in the facility(15).
Venous thrombosis occurs due to the continuous 
contact of the catheter with the endocardium, in the 
case of CVCSI, or endothelium, in the case of PICCs, 
which causes irritation, inflammation and the formation 
of thrombi. The prolonged presence of a CVC can cause 
blood clots in up to 70% of cases. Several factors 
might influence the incidence of thrombosis associated 
with CVCs, including composition, size, duration and 
number of entrances(16-17). One study revealed that the 
incidence of venous thrombosis in PICCs varies between 
4 and 38%. The factors that lead to the formation of 
a clot are trauma to the endothelial wall, interruption 
of therapy for a long period of time, reflux of blood 
through the catheter, and slow infusion. The incidence of 
thrombosis also increases as the diameter of catheters 
increases(12). 
The occurrence of venous thrombosis was observed 
only in CVCSIs in this study. The occurrence of all these 
events was related to the prolonged duration of the CVC: 
one event occurred on the 14th day of use, another on 
the 22nd day and the third event occurred on the 23rd day 
of the catheter’s use. 
Infiltration is the accumulation of non-irritating 
substances infused into the tissue surrounding the vein 
due to the displacement of the catheter from the vein’s 
intima to the subcutaneous tissue. Infiltration of vesicant 
solution is called extravasation(2). Studies present a 
frequency of infiltration equivalent to 3.7% (n=5) in 
PICCs and 3.8% (n=14) in CVCICs(8,18). This frequency 
is less than that presented in this study, which found a 
frequency of infiltration of 5.09% (n=11) for PICCs and 
12% (n=3) for CVCs.
Several events caused by the poor positioning of 
the catheter tip are described in the literature such 
as: pneumothorax, hydrothorax, hemothorax, hydro 
mediastinum, arteriovenous fistula, perforation and 
cardiac tamponade, among others(9,17). No adverse 
events occurred in this study due to poor catheter 
positioning. Such a fact is related to the intravenous 
therapy occurring after analysis of the first X-ray in 
which the need to retract the catheter or remove it 
due to inappropriate positioning is evaluated. The ideal 
positioning of the PICC is in the vena cava in the distal 
third of the thorax level and the CVCSI has to be placed 
between the vena cava and the right atrium(17).
A limitation was identified in this study. Because 
this is a retrospective study, the findings were based 
on medical records and were limited by access to 
information such as radiographic images and reports of 
the catheters’ X-rays.
Final considerations
Adverse events in central catheters were frequent 
in neonatal populations, both for PICCs as in CVCSIs. 
The most prevalent adverse event in PICCs was catheter 
occlusion, while clinical sepsis prevailed in CVCSIs.
PICCs presented a higher frequency of mechanical 
adverse events, especially catheter occlusion and 
rupture. However, its use presented very low rates of 
catheter-related infections; these rates are similar or 
less than those reported in the literature. Therefore, 
we assert that PICC is a safe means for parenteral 
administration in the neonatal population due to the low 
risk of infection found in this study and in the literature. 
The use of CVCSI resulted in a lower rate of mechanical 
adverse events: occlusions or ruptures were not found 
for this catheter in this study. However, the rates of 
infectious adverse events related to this catheter are the 
most prevalent.
This study’s findings reveal the need for further 
studies to evaluate the factors associated with the 
occurrence of sepsis in CVCSIs. In relation to PICCs, 
further research is suggested in order to investigate 
the factors associated with catheter occlusion. Studies 
identifying the factors that predispose PICCs to such 
adverse event can contribute to a safer use of PICCs.
The use of CVCs is essential to the survival of 
many newborns. We expect the results of this study to 
encourage the analysis of the patterns of occurrence 
of adverse events. We also assert the importance of a 
specialized and attentive team for the follow-up of CVCs 
in preventing such events.
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